Deutsche Bank
KYTX icon

Deutsche Bank’s Kyverna Therapeutics KYTX Stock Holding History

Deutsche Bank’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Buy
44,853
+40,936
+1,045% +$363K ﹤0.01% 2895
2026
Q1 		$33.8K Hold
3,917
– – ﹤0.01% 3508
2025
Q4 		$36.8K Hold
3,917
– – ﹤0.01% 3485
2025
Q3 		$23.5K Hold
3,917
– – ﹤0.01% 3492
2025
Q2 		$12K Buy
+3,917
New +$9.69K ﹤0.01% 3502
2025
Q1 		– Sell
-4,171
Closed -$15.6K – 3649
2024
Q4 		$15.6K Buy
+4,171
New +$20K ﹤0.01% 3499

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Deutsche Bank's KYTX Position: Q2 2026 in Review

Deutsche Bank increased its Kyverna Therapeutics (KYTX) stake by 1,045% in Q2 2026, buying an estimated $363K and bringing the position to 44,853 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2895.

Deutsche Bank first reported a position in KYTX in Q4 2024 and has held it in 6 quarters since. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Deutsche Bank held 44,853 shares of Kyverna Therapeutics worth $400K as of Q2 2026.
  • Deutsche Bank bought 40,936 Kyverna Therapeutics shares in Q2 2026, an estimated $363K.
  • Kyverna Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2895 holding.
  • Deutsche Bank first reported a position in Kyverna Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.